Prognia
Drug Database
🇪🇺EU · EMARefusedATC: M09AXOrphan Medicine

Exondys(eteplirsen)

Muscular Dystrophy, Duchenne

Marketing Authorisation Holder: AVI Biopharma International Ltd

INN: eteplirsen

Indication

Treatment of Duchenne muscular dystrophy.

Official EMA Resources

View on EMA (ema.europa.eu)

AI Drug & Interaction Analysis

Free account required

Ask Prognia AI about Exondys — dosing recommendations, drug interactions, and current guideline evidence from ESC, EMA, NICE and more.

Medical disclaimer: This information is intended for qualified healthcare professionals. Always verify with the official EMA Summary of Product Characteristics (SmPC) before clinical use.